Hamdan S Al-Malky
Overview
Explore the profile of Hamdan S Al-Malky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohite P, Yadav V, Pandhare R, Maitra S, Saleh F, Saleem R, et al.
ACS Omega
. 2024 Feb;
9(7):7277-7295.
PMID: 38405458
In the realm of cancer immunotherapy, a profound evolution has ushered in sophisticated strategies that encompass both traditional cancer vaccines and emerging viral vaccines. This comprehensive Review offers an in-depth...
2.
Alenzi K, Al-Malky H, Altebainawi A, Abushomi H, Alatawi F, Atwadi M, et al.
Front Public Health
. 2022 Nov;
10:927494.
PMID: 36388318
Background: The coronavirus disease 2019 (COVID-19) pandemic has added a massive economic burden on health care systems worldwide. Saudi Arabia is one of the numerous countries that have been economically...
3.
Rahman M, Bibi S, Rahaman M, Rahman F, Islam F, Khan M, et al.
Biomed Pharmacother
. 2022 Jun;
150:113041.
PMID: 35658211
Background: Lung diseases including chronic obstructive pulmonary disease (COPD), infections like influenza, acute respiratory distress syndrome (ARDS), asthma and pneumonia lung cancer (LC) are common causes of sickness and death...
4.
Damiri F, Rahman M, Zehravi M, Awaji A, Nasrullah M, Gad H, et al.
Materials (Basel)
. 2022 Mar;
15(5).
PMID: 35268907
Polymeric nanocomposites have been outstanding functional materials and have garnered immense attention as sustainable materials to address multi-disciplinary problems. MXenes have emerged as a newer class of 2D materials that...
5.
Damiri F, Kommineni N, Ebhodaghe S, Bulusu R, Jyothi V, Sayed A, et al.
Pharmaceuticals (Basel)
. 2022 Feb;
15(2).
PMID: 35215302
In this focused progress review, the most widely accepted methods of transdermal drug delivery are hypodermic needles, transdermal patches and topical creams. However, microneedles (MNs) (or microneedle arrays) are low-invasive...
6.
Goyal A, Sharma A, Kaur J, Kumari S, Garg M, Sindhu R, et al.
Molecules
. 2022 Feb;
27(3).
PMID: 35164093
Cosmetic-containing herbals are a cosmetic that has or is claimed to have medicinal properties, with bioactive ingredients purported to have medical benefits. There are no legal requirements to prove that...
7.
Kabir M, Rahman M, Shah M, Jamiruddin M, Basak D, Al-Harrasi A, et al.
Biomed Pharmacother
. 2022 Jan;
146:112610.
PMID: 35062074
Neurodegenerative disorders (NDs) including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis have various disease-specific causal factors and pathological features. A very common characteristic of NDs...
8.
Al-Malky H, Al Harthi S, Osman A
J Oncol Pharm Pract
. 2019 Oct;
26(2):434-444.
PMID: 31594518
Background: Doxorubicin is one of the most commonly prescribed and time-tested anticancer drugs. Although being considered as a first line drug in different types of cancers, the two main obstacles...
9.
Al-Malky H, Osman A, Damanhouri Z, AlKreathy H, Al Aama J, Ramadan W, et al.
Cancer Cell Int
. 2019 Aug;
19:191.
PMID: 31367189
Background: Doxorubicin (DOX) is one of the most important anticancer agents used in treating breast cancer. However, chronic cardiotoxicity and multidrug resistance limit the chemotherapeutic use of DOX. Methods: This...